Antitrust disposals on horizon for Nestlé
Analysts say the Swiss group will have to sell between 20-40% of the $ 2.1bn Pfizer infant nutrition business it plans to acquire to satisfy regulators
FT.com – European companies
Analysts say the Swiss group will have to sell between 20-40% of the $ 2.1bn Pfizer infant nutrition business it plans to acquire to satisfy regulators
FT.com – European companies